About Probable G-protein coupled receptor 27
Probable G-protein coupled receptor 27 (GPR27) is a protein
from Homo sapiens identified by UniProt accession
Q9NS67, 375 residues long.
MolForge cross-references it against 0 known binders and
88 disease associations.
Target properties
| Protein name | Probable G-protein coupled receptor 27 |
| UniProt accession | Q9NS67 |
| Gene | GPR27 |
| Organism | Homo sapiens |
| Length | 375 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (88)
Diseases linked to this target (Open Targets).
- monocyte count · score 0.38
- neuroticism measurement · score 0.31
- eosinophil count · score 0.25
- serum albumin measurement · score 0.21
- monocyte percentage of leukocytes · score 0.20
- mosaic loss of chromosome Y measurement · score 0.17
- apolipoprotein A 1 measurement · score 0.16
- eosinophil percentage of leukocytes · score 0.14
- hair shape measurement · score 0.14
- mitochondrial DNA measurement · score 0.14
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9NS67-F1 | alphafold | PREDICTED | 78.67 | — |
Amino-acid sequence (375 residues)
MANASEPGGS GGGEAAALGL KLATLSLLLC VSLAGNVLFA LLIVRERSLH RAPYYLLLDL CLADGLRALA CLPAVMLAAR RAAAAAGAPP GALGCKLLAF LAALFCFHAA FLLLGVGVTR YLAIAHHRFY AERLAGWPCA AMLVCAAWAL ALAAAFPPVL DGGGDDEDAP CALEQRPDGA PGALGFLLLL AVVVGATHLV YLRLLFFIHD RRKMRPARLV PAVSHDWTFH GPGATGQAAA NWTAGFGRGP TPPALVGIRP AGPGRGARRL LVLEEFKTEK RLCKMFYAVT LLFLLLWGPY VVASYLRVLV RPGAVPQAYL TASVWLTFAQ AGINPVVCFL FNRELRDCFR AQFPCCQSPR TTQATHPCDL KGIGL
Explore Probable G-protein coupled receptor 27 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets